PDS Biotech has recently outlined a revised regulatory timeline in light of an amendment to its VERSATILE-003 protocol. This adjustment reflects the company's commitment to ensuring a streamlined process for…

BOULDER, Colo., March 30, 2026 (GLOBE NEWSWIRE) – Auddia Inc. (NASDAQ: AUUD) has announced the release of a significant whitepaper by LT350, titled Distributed, Power-Sovereign AI Infrastructure for the Inference…

The glass reactor market is experiencing significant expansion, propelled by the increasing demand from the pharmaceutical, chemical, and research sectors for high-purity, corrosion-resistant reaction vessels. These specialised vessels are designed…

Global markets are currently navigating a complex landscape as geopolitical tensions and technological advancements intersect. Escalating tensions in the Middle East have led to a significant increase in oil prices,…

CINCINNATI - Onconetix, a publicly traded biotechnology firm based in downtown Cincinnati, has announced the appointment of David White as its new Chief Executive Officer, marking a significant leadership change…

The BRIC-National Agri-Food and Biomanufacturing Institute (BRIC-NABI), an autonomous institute under the Department of Biotechnology, Government of India, is seeking qualified candidates for a Consultant position in Regulatory Affairs and…

Pharmaceutical giant Eli Lilly has announced a significant partnership with a biotechnology firm based in Hong Kong, entering into a deal valued at $2 billion aimed at advancing drug development…

Ace Therapeutics has announced the introduction of its comprehensive platform of preclinical genetic kidney disease models, aimed at accurately replicating human hereditary renal pathology. This initiative is designed to bolster…

Lixte Biotech Holdings (NASDAQ: LIXT) is making significant strides in the realm of precision oncology through the development of LB-100, a first-in-class therapy aimed at enhancing the effectiveness of established…